Thursday, December 7, 2017 - 07:00

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its financial calendar for 2018, which is set as follows:

 

March 8, 2018:           Publication of 2017 financial statements, with management comments.

The 2017 Reference Document and Financial Report (included in the Reference Document) will be released during the second quarter of 2018.

May 16, 2018:            Publication of revenue for 1Q2018, with management comments.

May 29, 2018:            Annual shareholders meeting in Marseille.

September 17, 2018:   Publication of financial statements as of June 30, 2018, with management comments.

November 15, 2018:    Publication of revenue for 3Q2018, with management comments.

 

All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the Investors’ section (www.innate-pharma.com/en/investors).

AttachmentSize
PR in English69.56 KB
CP en français70.4 KB